Outcomes Following Treatment of Maternal Hypercalcemia Due to CYP24A1 Pathogenic Variants

Detalles Bibliográficos
Autores principales: McBride, Lucy, Houlihan, Christine, Quinlan, Catherine, Messazos, Betty, Stark, Zornitza, Crosthwaite, Amy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Nephrology Round
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551508/
https://www.ncbi.nlm.nih.gov/pubmed/31194112
http://dx.doi.org/10.1016/j.ekir.2019.02.018
_version_ 1783424404656488448
author McBride, Lucy
Houlihan, Christine
Quinlan, Catherine
Messazos, Betty
Stark, Zornitza
Crosthwaite, Amy
author_facet McBride, Lucy
Houlihan, Christine
Quinlan, Catherine
Messazos, Betty
Stark, Zornitza
Crosthwaite, Amy
author_sort McBride, Lucy
collection PubMed
description
format Online
Article
Text
id pubmed-6551508
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-65515082019-06-10 Outcomes Following Treatment of Maternal Hypercalcemia Due to CYP24A1 Pathogenic Variants McBride, Lucy Houlihan, Christine Quinlan, Catherine Messazos, Betty Stark, Zornitza Crosthwaite, Amy Kidney Int Rep Nephrology Round Elsevier 2019-03-08 /pmc/articles/PMC6551508/ /pubmed/31194112 http://dx.doi.org/10.1016/j.ekir.2019.02.018 Text en © 2019 International Society of Nephrology. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Nephrology Round
McBride, Lucy
Houlihan, Christine
Quinlan, Catherine
Messazos, Betty
Stark, Zornitza
Crosthwaite, Amy
Outcomes Following Treatment of Maternal Hypercalcemia Due to CYP24A1 Pathogenic Variants
title Outcomes Following Treatment of Maternal Hypercalcemia Due to CYP24A1 Pathogenic Variants
title_full Outcomes Following Treatment of Maternal Hypercalcemia Due to CYP24A1 Pathogenic Variants
title_fullStr Outcomes Following Treatment of Maternal Hypercalcemia Due to CYP24A1 Pathogenic Variants
title_full_unstemmed Outcomes Following Treatment of Maternal Hypercalcemia Due to CYP24A1 Pathogenic Variants
title_short Outcomes Following Treatment of Maternal Hypercalcemia Due to CYP24A1 Pathogenic Variants
title_sort outcomes following treatment of maternal hypercalcemia due to cyp24a1 pathogenic variants
topic Nephrology Round
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551508/
https://www.ncbi.nlm.nih.gov/pubmed/31194112
http://dx.doi.org/10.1016/j.ekir.2019.02.018
work_keys_str_mv AT mcbridelucy outcomesfollowingtreatmentofmaternalhypercalcemiaduetocyp24a1pathogenicvariants
AT houlihanchristine outcomesfollowingtreatmentofmaternalhypercalcemiaduetocyp24a1pathogenicvariants
AT quinlancatherine outcomesfollowingtreatmentofmaternalhypercalcemiaduetocyp24a1pathogenicvariants
AT messazosbetty outcomesfollowingtreatmentofmaternalhypercalcemiaduetocyp24a1pathogenicvariants
AT starkzornitza outcomesfollowingtreatmentofmaternalhypercalcemiaduetocyp24a1pathogenicvariants
AT crosthwaiteamy outcomesfollowingtreatmentofmaternalhypercalcemiaduetocyp24a1pathogenicvariants

Ejemplares similares